GGrantIndex
Sort

15,440 grants matching organoids

ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC

$476,859
John R Hawse · Mayo Clinic Rochester · R01 · FY2024 · CA

Engineered hybrid aging model for disease progression

$476,827
Pinar Zorlutuna · University Of Notre Dame · R01 · FY2023 · CA

Trophoblast development and placental susceptibility to cytomegalovirus infection

$476,771
Craig John Bierle · University Of Minnesota · R01 · FY2023 · HD

Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells

$476,737
Qingfei Jiang · University Of California, San Diego · R01 · FY2025 · CA

Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy

$476,736
Xinna Zhang · Indiana University Indianapolis · R01 · FY2024 · CA

Targeting CEBPA To Restore Epithelial-Mesenchymal Homeostasis In Lung Fibrosis

$476,658
Qi Tan · Mayo Clinic Rochester · R01 · FY2020 · HL

Intestinal Metabolic Reprogramming as a Key Mechanism of Gastric Bypass in Humans

$476,643
Nicholas Stylopoulos · Boston Children'S Hospital · R01 · FY2019 · DK

An electrophysiology platform that enables robust, scalable and long-term intracellular recording of cardiomyocytes

$476,598
Bianxiao Cui · Stanford University · R01 · FY2022 · HL

NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer

$476,566
Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2024 · CA

Mitigation of Radiation Damage to the Immunohematopoietic System

$476,431
William H. McBride · University Of California Los Angeles · U19 · FY2011 · AI

Elucidate the Role of RNA Editing in Acute T-cell Lymphoblastic Leukemia Initiating Cells

$476,234
Qingfei Jiang · University Of California, San Diego · R01 · FY2024 · CA

Molecular Cytology

$476,034
Katia Ognianova Manova · Sloan-Kettering Inst Can Research · P30 · FY2019 · CA

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$475,865
Timothy Patrick Spicer · Scripps Florida · R33 · FY2017 · CA

Interstitial resident fibroblasts direct alveolar epithelial differentiation

$475,847
Anne-Karina Theresia Perl · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · HL

Interstitial resident fibroblasts direct alveolar epithelial differentiation

$475,847
Anne-Karina Theresia Perl · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · HL

Interstitial resident fibroblasts direct alveolar epithelial differentiation

$475,847
Anne-Karina Theresia Perl · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · HL

Coordinated regulation of alternative pre-mRNA processing in colon cancer

$475,840
Klemens J Hertel · University Of California-Irvine · R01 · FY2016 · CA

Coordinated regulation of alternative pre-mRNA processing in colon cancer

$475,840
Klemens J Hertel · University Of California-Irvine · R01 · FY2017 · CA

PARP1-Chromatin and NAD-Metabolism in EBV Epithelial Cancers

$475,815
Italo Tempera · Wistar Institute · P01 · FY2025 · CA

Olfactory neuroepithelial cell derived induced neurons for study of schizophrenia

$475,813
Chang-Gyu Hahn · Thomas Jefferson University · R21 · FY2023 · MH

Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy

$475,484
Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2021 · CA

Induction and Evolution of Metaplasia in the Stomach

$475,482
James R Goldenring · Vanderbilt University Medical Center · R01 · FY2019 · DK

Deciphering mechanisms of transcriptional repression which drive midline glioma

$475,431
Richard E Phillips · University Of Pennsylvania · R01 · FY2024 · CA

Developing new therapeutic strategies for distinct Ras-driven cancers

$475,403
Karen M Cichowski · Brigham And Women'S Hospital · R01 · FY2022 · CA

FOXO3 dependent proinflammatory transcription program of AD

$475,377
Tae-Wan Kim · Columbia University Health Sciences · R21 · FY2025 · AG